The National Core Studies consists of six programmes:
- Epidemiology and Surveillance – collecting data to inform safe level of restrictions and protection against imminent outbreaks (led by Ian Diamond, UK National Statistician, ONS).
- Clinical Trials Infrastructure – building on established NIHR infrastructure (and equivalent in Devolved Administrations) to accelerate delivery of large scale Covid trials for drugs and vaccines. (led by Patrick Chinnery, Clinical Director, MRC and Divya Chadha Manek, Head of Business Development, Vaccines Task Force).
- Transmission and Environment (also known as PROTECT) – improving our understanding of how the virus is transmitted in different settings and environments, including in workplaces, on transport and in other public places (led by Andrew Curran, Chief Scientific Adviser, Health and Safety Executive).
- Immunity – understanding immunity against Covid to inform back-to-work policies (led by Paul Moss Professor of Haematology, University of Birmingham).
- Longitudinal Health and Wellbeing – using data from longitudinal studies to address the impact of COVID-19 and of associated viral suppression measures on health and wealth to inform mitigating strategies (led by Nishi Chaturvedi, Professor of Clinical Epidemiology, University College London).
- Data and Connectivity – making data from all studies available and accessible to inform decision makers and catalyse COVID-19 research (led by Andrew Morris Director, HDR UK).